Clinical Trials at University Medical Center New Orleans

As of August 2026, 51 paid clinical trials are recruiting at University Medical Center New Orleans, located at 1532 TULANE AVE, NEW ORLEANS, LA 70112-2860, phone (504) 903-3000 in New Orleans, Louisiana. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 10, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

51 clinical trials at University Medical Center New Orleans

·Clear filters·

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

for Gastric Adenocarcinoma

Sites in New Orleans +54 more locations

Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All·Age: 18+

Code: NCT07001748·Phase 2, Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

for Anatomic Stage IV Breast Cancer AJCC v8

Sites in New Orleans, Marrero +584 more locations

Sponsor: SWOG Cancer Research Network

Sex: All·Age: 18+

Code: NCT03723928·Recruiting·Listed Oct 2018

Apply to this trial

Collection of SARS CoV-2 (COVID-19) Virus Secretions and Serum for Countermeasure Development

for Covid19

2 locations in New Orleans

Sponsor: Tulane University

Sex: All·Age: 6 Months - 120·Accepts healthy volunteers

Code: NCT04956445·Recruiting·Listed Jul 2021

Apply to this trial

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

for Stage III Ovarian Cancer

Drug: Niraparib

Sites in New Orleans +58 more locations

Sponsor: GOG Foundation

Sex: Female·Age: 18+

Code: NCT05659381·Phase 3·Recruiting·Listed Dec 2022

Apply to this trial

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

for Anatomic Stage I Breast Cancer AJCC v8

Sites in New Orleans, Marrero +913 more locations

Sponsor: SWOG Cancer Research Network

Sex: All·Age: 18+

Code: NCT05929768·Phase 3·Recruiting·Listed Jul 2023

Apply to this trial

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

for Metastatic Clear Cell Renal Cell Carcinoma

Sites in New Orleans, Metairie +338 more locations

Sponsor: SWOG Cancer Research Network

Sex: All·Age: 18+

Code: NCT04510597·Phase 3·Recruiting·Listed Aug 2020

Apply to this trial

Vitamin D for Prostate Endocrine Therapy

for Stage I Prostate Cancer AJCC v8

Sites in New Orleans +50 more locations

Sponsor: University of Rochester

Sex: Male·Age: 50+

Code: NCT05838716·Phase 3·Recruiting·Listed May 2023

Apply to this trial

Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer

for Locally Advanced Hepatocellular Carcinoma

Drug: Atezolizumab

Sites in New Orleans +11 more locations

Sponsor: Academic and Community Cancer Research United

Sex: All·Age: 18+

Code: NCT05168163·Phase 2·Recruiting·Listed Dec 2021

Apply to this trial

VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study

for Crohn's Disease

Sites in New Orleans +10 more locations

Sponsor: Alimentiv Inc.

Sex: All·Age: 18+

Code: NCT06249555·Recruiting·Listed Feb 2024

Apply to this trial

Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV

for Papillomavirus Vaccines

1 location in New Orleans

Sponsor: Louisiana State University Health Sciences Center in New Orleans

Sex: All·Age: 18 - 65·Accepts healthy volunteers

Code: NCT05266898·Phase 4·Recruiting·Listed Mar 2022

Apply to this trial

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

for Endometrial Carcinoma

Sites in New Orleans, Metairie +325 more locations

Sponsor: National Cancer Institute (NCI)

Sex: Female·Age: 18+

Code: NCT05256225·Phase 3·Recruiting·Listed Feb 2022

Apply to this trial